Zimmer Biomet (ZBH) - Biznesning o‘zini qoplash muddati

zimmerbiomet.com (ZBH) korporativ emblemasi va logotipi

Zimmer Biomet Holdings (ZBH) tashqi pudratchilar va logistikani autsorsing qilish orqali mahsulot ishlab chiqarishni optimallashtirmoqda. Murakkab tizimlar uchun patentlar va FDA ning qat'iy nazorati bilan tasdiqlanganidek, bu yangi mahsulotlarning bozorga chiqishini tezlashtiradi. Emitentning P/E koeffitsiyenti kapital rentabelligi dinamikasini aks ettiradi, bunda parametr 25.10 darajasida barqarorlashgan. Yuqori almashtirish xarajatlari va jarrohlar sodiqligi kompaniyaning bozor pozitsiyalarini deyarli yengilmas darajaga keltirgan.

ZBH (Zimmer Biomet Holdings) P/E multiplikatori tarixi 04.07.2022dan 17.11.2026gacha

zimmerbiomet.com (ZBH) kompaniyasining tahliliy kesimlari

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning har tomonlama tahlili:ZBH Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings tovar namunasi

Zimmer Biomet Holdings (ZBH) uchun fundamental xatarlar bozor kapitalizatsiyasining sof foydaga nisbati orqali baholanadi. Implantlar ishlab chiqarishning murakkabligi va qat'iy tibbiy standartlar emitent pul oqimlarining barqarorligini ta'minlaydi. Biznesning P/E baholashi hissiy shovqinlarni filtrlash imkonini beradi va aktivlarning real qiymatini ularning rentabelligiga nisbatan namoyish etadi. Ushbu ko'rsatkichning barqaror egri chizig'i modelning yetukligini tasdiqlaydi va investorlarni narx cho'qqilari paytidagi impulsiv xaridlardan himoya qiladi.

Muhim raqobatchilar

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|COO (The Cooper Companies) - Kapitalizatsiyaning sof foydaga nisbati|ALGN: Narx-foyda koeffitsiyenti|Kapitalizatsiyaning sof foydaga nisbati GMED|TMDX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati ATEC Spine (ATEC)|AORT (Artivion) - P/E multiplikatori|Narx-foyda multiplikatori ENOV (Enovis)|Narx-foyda koeffitsiyenti IART (Integra LifeSciences Holdings Corporation)|ESTA (Establishment Labs Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati iLet Bionic Pancreas BBNX|IRMD - Narx-foyda koeffitsiyenti|Embecta Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Tandem Diabetes Care|AXGN: P/E multiplikatori|Narx-foyda multiplikatori SIBN|OFIX (Orthofix Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti Bioventus Corp (BVS)|P/E multiplikatori KIDS|Narx-foyda koeffitsiyenti Treace Medical Concepts TMCI|P/E multiplikatori SRTA (blade.com)|P/E multiplikatori Carlsmed, Inc. CARL|RXST - Narxning foydaga nisbati|CLPT: Narxning foydaga nisbati|STXS (Stereotaxis, Inc.) - Narx-foyda koeffitsiyenti|Neuronetics, Inc. - Kompaniya qiymatining sof foydaga nisbati|SGHT (Sight Sciences Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Orchestra BioMed Inc. OBIO|Narxning foydaga nisbati Anika Therapeutics, Inc. (ANIK)|InspireMD, Inc. (NSPR) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Jin Medical International Ltd. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)